Sparsentan (Filspari) becomes the first approved treatment specifically for focal segmental glomerulosclerosis. 2. Clinical ...

In this retrospective cohort study, approximately 30% of veterans hospitalized for alcohol use disorder received medications ...

In clinically stable patients with prior intracerebral hemorrhage, a fixed-dose combination pill containing three low-dose ...

Five days of accelerated continuous theta burst stimulation (a-cTBS) targeting the left primary motor cortex improved social ...

Daraxonrasib significantly improves survival in metastatic pancreatic cancer compared with standard chemotherapy. 2. Strong response rates in combination therapy suggest broader potential across ...

Shipping slowdowns in the Strait of Hormuz are disrupting the movement of key pharmaceutical ingredients and finished generic ...

Robotic component separation for ventral hernia repair was associated with lower postoperative complication rates, shorter ...

Perianal 2% lidocaine gel significantly reduced anal pain and shortened cecal intubation time during unsedated colonoscopy in ...

In this randomized controlled trial, a 1 L polyethylene glycol–ascorbate regimen achieved higher rates of high-quality bowel ...

In two large randomized platform trials, early treatment with nirmatrelvir–ritonavir did not reduce hospitalization or death ...

In this cross-sectional study, amputation rates increased more rapidly among opioid-related than among non-opioid-related ...

In frail, elderly patients with non-ST-segment elevation myocardial infarction (NSTEMI), invasive management with coronary ...